Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2efe973aa580fa19151071b7d9f69248 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 |
filingDate |
2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64b26ac29470159df11b790d9e6b6a85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a87d8a6434fd7873876aaa0fc4bd569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f58985e6d85350d2b5d480ee2d4f588 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56f80e94f58807e4f673642558df96d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba40e9586b565b8972b0cb0e90104b09 |
publicationDate |
2021-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102308854-B1 |
titleOfInvention |
The pharmaceutical composition for prevention and treatment of coronavirus disease-19 containing carbocyclic nucleosides derivatives |
abstract |
The present invention relates to a pharmaceutical composition for preventing or treating coronavirus infection-19 (COVID-19), specifically, a carbocyclic nucleoside derivative represented by Formula A-1 or Formula A-2 Or it relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt thereof. |
priorityDate |
2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |